These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28003837)

  • 1. A quantitative structure-activity relationship (QSAR) study of some diaryl urea derivatives of B-RAF inhibitors.
    Sadeghian-Rizi S; Sakhteman A; Hassanzadeh F
    Res Pharm Sci; 2016 Dec; 11(6):445-453. PubMed ID: 28003837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D-QSAR studies of some reversible Acetyl cholinesterase inhibitors based on CoMFA and ligand protein interaction fingerprints using PC-LS-SVM and PLS-LS-SVM.
    Ghafouri H; Ranjbar M; Sakhteman A
    Comput Biol Chem; 2017 Aug; 69():19-27. PubMed ID: 28544873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docking and QSAR analysis of tetracyclic oxindole derivatives as α-glucosidase inhibitors.
    Asadollahi-Baboli M; Dehnavi S
    Comput Biol Chem; 2018 Oct; 76():283-292. PubMed ID: 30103106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Docking Guided Comparative GFA, G/PLS, SVM and ANN Models of Structurally Diverse Dual Binding Site Acetylcholinesterase Inhibitors.
    Gupta S; Fallarero A; Vainio MJ; Saravanan P; Santeri Puranen J; Järvinen P; Johnson MS; Vuorela PM; Mohan CG
    Mol Inform; 2011 Aug; 30(8):689-706. PubMed ID: 27467261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of potential anti-tumor PARP-1 inhibitors by QSAR and molecular modeling studies.
    Abbasi-Radmoghaddam Z; Riahi S; Gharaghani S; Mohammadi-Khanaposhtanai M
    Mol Divers; 2021 Feb; 25(1):263-277. PubMed ID: 32140890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QSAR prediction of HIV-1 protease inhibitory activities using docking derived molecular descriptors.
    Fatemi MH; Heidari A; Gharaghani S
    J Theor Biol; 2015 Mar; 369():13-22. PubMed ID: 25600056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of highly potent V600E-B-RAF kinase inhibitors: Molecular modeling study.
    Tarazi H; El-Gamal MI; Oh CH
    Bioorg Med Chem; 2019 Feb; 27(4):655-663. PubMed ID: 30660499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular dynamics simulation, free energy calculation and structure-based 3D-QSAR studies of B-RAF kinase inhibitors.
    Yang Y; Qin J; Liu H; Yao X
    J Chem Inf Model; 2011 Mar; 51(3):680-92. PubMed ID: 21338122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study on quantitative structure-activity relationship and molecular docking of metalloproteinase inhibitors based on L-tyrosine scaffold.
    Abbasi M; Ramezani F; Elyasi M; Sadeghi-Aliabadi H; Amanlou M
    Daru; 2015 Apr; 23(1):29. PubMed ID: 25925871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of MLR and SVM Aided QSAR Models to Identify Common SAR of GABA Uptake Herbal Inhibitors used in the Treatment of Schizophrenia.
    Marunnan SM; Pulikkal BP; Jabamalairaj A; Bandaru S; Yadav M; Nayarisseri A; Doss VA
    Curr Neuropharmacol; 2017 Nov; 15(8):1085-1092. PubMed ID: 27919211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validated QSAR analysis of some diaryl substituted pyrazoles as CCR2 inhibitors by various linear and nonlinear multivariate chemometrics methods.
    Arkan E; Shahlaei M; Pourhossein A; Fakhri K; Fassihi A
    Eur J Med Chem; 2010 Aug; 45(8):3394-406. PubMed ID: 20493592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive QSAR modeling of CCR5 antagonist piperidine derivatives using chemometric tools.
    Roy K; Mandal AS
    J Enzyme Inhib Med Chem; 2009 Feb; 24(1):205-23. PubMed ID: 18608745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational Design of Colchicine Derivatives as anti-HIV Agents via QSAR and Molecular Docking.
    Worachartcheewan A; Songtawee N; Siriwong S; Prachayasittikul S; Nantasenamat C; Prachayasittikul V
    Med Chem; 2019; 15(4):328-340. PubMed ID: 30251609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives.
    Mandal AS; Roy K
    Eur J Med Chem; 2009 Apr; 44(4):1509-24. PubMed ID: 18760864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular docking and QSAR studies of aromatase inhibitor androstenedione derivatives.
    Roy PP; Roy K
    J Pharm Pharmacol; 2010 Dec; 62(12):1717-28. PubMed ID: 21054398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docking and QSAR Studies of 1,4-Dihydropyridine Derivatives as Anti- Cancer Agent.
    Mollazadeh S; Shamsara J; Iman M; Hadizadeh F
    Recent Pat Anticancer Drug Discov; 2017; 12(2):174-185. PubMed ID: 28137213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of B-Raf[Formula: see text] inhibitors using 2D and 3D-QSAR, molecular docking and pharmacophore studies.
    Aalizadeh R; Pourbasheer E; Ganjali MR
    Mol Divers; 2015 Nov; 19(4):915-30. PubMed ID: 26276566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CoMFA and CoMSIA 3D QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: exploration of a binding mode at the active site.
    Buolamwini JK; Assefa H
    J Med Chem; 2002 Feb; 45(4):841-52. PubMed ID: 11831895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonicotinoid insecticide design: molecular docking, multiple chemometric approaches, and toxicity relationship with Cowpea aphids.
    Bora A; Suzuki T; Funar-Timofei S
    Environ Sci Pollut Res Int; 2019 May; 26(14):14547-14561. PubMed ID: 30877540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2D-QSAR Modeling and Molecular Docking Studies on 1
    Hajalsiddig TTH; Osman ABM; Saeed AEM
    ACS Omega; 2020 Aug; 5(30):18662-18674. PubMed ID: 32775868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.